Hypersensitivity pneumonitis differential diagnosis
Hypersensitivity pneumonitis Microchapters |
Differentiating Hypersensitivity pneumonitis from other Diseases |
---|
Diagnosis |
Treatment |
Hypersensitivity pneumonitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Hypersensitivity pneumonitis differential diagnosis |
Hypersensitivity pneumonitis differential diagnosis in the news |
Blogs on Hypersensitivity pneumonitis differential diagnosis |
Directions to Hospitals Treating Hypersensitivity pneumonitis |
Risk calculators and risk factors for Hypersensitivity pneumonitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The differential diagnosis of hypersensitivity pneumonitis is, primarily, a group of diseases known as idiopathic interstitial pneumonias. This group of diseases includes idiopathic pulmonary fibrosis (IPF) (which manifests histologically as usual interstitial pneumonia (UIP)), idiopathic non-specific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia, among others. There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of Hypersensitivity Pneumonitis.
Differential Diagnosis
Other diseases that are secondary to inhalation of organic agents but are not true forms of HP are as follows:
- Inhalation fever: Patients present with fever, chills, headache, and myalgias however there are not pulmonary findings (although mild dyspnea may occur). Onset is 4-8 hours following exposure. There are no long-term sequelae occur.
- Organic dust toxic syndrome: This syndrome is the result of exposure to bioaerosols contaminated with toxin-producing fungi (mycotoxins). Patients present with fever, chills, and myalgias 4-6 hours after exposure. In contrast to inhalation fever, the chest X ray may show diffuse opacities. Bronchiolitis or diffuse alveolar damage may be present on lung biopsy specimens. This is not a true form of HP because no prior sensitization is required.
- Chronic bronchitis: This can result from chronic obstructive pulmonary disease, which is the most common respiratory syndrome among agricultural workers. The prevalence of chronic bronchitis is much higher at 10%, compared with 1.4% for HP.
- Exposure to aerosolized Mycobacterium avium complex (MAC): A hypersensitivity pneumonitis like syndrome has been described in patients exposed to aerosolized Mycobacterium avium complex (MAC). Hot tub lung is a term used to describe these hypersensitivity pneumonitis-like cases because they have generally been associated with hot tub use. The syndrome has been linked to the high levels of infectious aerosols containing MAC organisms found in the water. Whether this syndrome represents a true MAC infection or classic HP remains controversial (Marras, 2005).
By frequency of Interstitial Lung Diseases (Xaubet, 2004):
- Idiopathic pulmonary fibrosis (38.6%)
- Sarcoidosis (14.9%)
- Cryptogenic organizing pneumonia (10.4%)
- Interstitial lung disease associated with collagen vascular diseases (9.9%)
- Hypersensitivity Pneumonitis (HP) (6.6%)
- Unclassified (5.1%)
In alphabetical order:
- Air-conditioner lung
- Aspergillus clavatus
- Bagassosis
- Bird breeder's lung
- Bird fancier's lung
- Cheese worker's lung
- Chemical worker's lung
- Cladosporium
- Farmer's lung
- Grain handler's lung
- Humidifier lung
- Malt worker's lung
- Micropolyspora faeni
- Mollusk shell hypersensitivity
- Mucor stolonifer
- Paprika splitter's lung
- Penicillium casei
- Saccharopolyspora rectivirgula
- Sitophilus granarius
- Thermoactinomyces sacchari
- Thermoactinomyces vulgaris
Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, bronchitis, hypersensitivity pneumonitis, pneumoconiosis.
Pulmonary Function Test | Obstructive Lung Disease | Restrictive Lung Disease |
---|---|---|
TLC | ↑ | ↓ |
RV | ↑ | ↓ |
FVC | ↓ | ↓ |
FEV1 | ↓↓ | ↓ |
FEV1/FVC | ↓ | N to ↑ |
MVV | ↓ | ↓ |
Approach to Lung Disorders
Spirometry | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low FEV1/FVC ratio | Normal to high FEV1/FVC ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obstructive Lung Disease | Restrictive Lung Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bronchodilator therapy | DLCO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increased FEV1 | No change in FEV1 | Normal DLCO | Decreased DLCO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asthma | COPD | Chest wall disorders | Interstitial Lung Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Spirometry Findings in Various Lung Conditions
Disease | Clinical manifestations | Diagnosis | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical exam | Lab findings | Imaging | Gold standard | |||||||||||||
Cough | Dyspnea | Hemoptysis | Fever | History/Exposure | Cyanosis | Clubbing | JVD | Peripheral edema | Auscultation | Other prominent findings | CXR | CT | DLCco | ||||
Acute Respiratory Distress Syndrome (ARDS) | - | + | - | - | + | - | - | - |
|
|
|
|
|
↓ |
| ||
Bronchitis | Acute | + | - | +/- | + | - | - | - | - | - |
|
|
|
- |
| ||
Chronic | + | + | - | - |
|
+ | - | + | + |
|
|
|
|
↓ |
| ||
Hypersensitivity Pneumonitis | + | + | - | + |
|
- | + | - | - |
|
|
|
|
|
↓ |
| |
Pneumoconiosis[1] | SIlicosis[2][3] | + | + | +/- | - |
|
+ | + | + | - |
|
|
|
|
|
↓ | |
Asbestosis |
|
|
| ||||||||||||||
Berylliosis |
|
- |
|
| |||||||||||||
Byssinosis |
|
|
|
| |||||||||||||
Sarcoidosis | + | + | + | + |
|
- | - | - | - |
|
|
|
|
|
↓ | ||
Pleural Effusion | + | + | +/- | +/- | Transudate
Exudate |
+/- | +/- | +/- | +/- |
|
|
|
Supine
Lateral decubitus
|
|
↓ | ||
Interstitial (Nonidiopathic) Pulmonary Fibrosis | + | ++ | + | - | + | + | + | + |
|
|
|
↓ | Video-assisted thoracoscopic lung biopsy | ||||
Lymphocytic Interstitial Pneumonia[4] | + | + | + | + | - | + | - | - |
|
|
|
|
N | Open lung biopsy | |||
Obesity[5][6] | + | + | - | - |
|
- | - | - | + | - |
|
|
N | Clinical | |||
Pulmonary Eosinophilia[7] | + | + | + | + | Infections | + | - | + | + |
|
|
|
|
↓ | Biopsy of lesion (skin or lung) | ||
Neuromuscular disease | Scoliosis | - | + | - | - |
|
- | - | - | - |
|
|
|
|
|
N |
|
Muscular dystrophy | - | + | - | - |
|
- | - | - | - |
|
|
|
N | ||||
ALS | - | + | - | - |
|
- | - | - | - |
|
|
N/A | Not significant/diagnostic | Not significant/diagnostic | - |
| |
Myasthenia gravis | - | + | - | + | H/O of difficulty getting up from chair
|
- | - | - | - |
|
|
|
|
|
N |
References
- ↑ Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
- ↑ du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
- ↑ Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.
- ↑ Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H (1999). "Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT". AJR Am J Roentgenol. 173 (1): 71–4. doi:10.2214/ajr.173.1.10397102. PMID 10397102.
- ↑ Zammit C, Liddicoat H, Moonsie I, Makker H (2010). "Obesity and respiratory diseases". Int J Gen Med. 3: 335–43. doi:10.2147/IJGM.S11926. PMC 2990395. PMID 21116339.
- ↑ O’Neill, Donal (2015). "Measuring obesity in the absence of a gold standard". Economics & Human Biology. 17: 116–128. doi:10.1016/j.ehb.2015.02.002. ISSN 1570-677X.
- ↑ de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML (2009). "Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma". Am. J. Trop. Med. Hyg. 81 (3): 424–7. PMID 19706907.